Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | mRNA-2752 |
Trade Name | |
Synonyms | mRNA2752|mRNA 2752 |
Drug Descriptions |
mRNA-2752 consists of an mRNA encoding OX40L, IL-23, and IL-36gamma encapsulated in a lipid nanoparticle, which may enhance antitumor immune response (Cancer Res (2024) 84 (6_Supplement): 6552). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C157247 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Durvalumab + mRNA-2752 | Durvalumab mRNA-2752 | 0 | 1 |
mRNA-2752 | mRNA-2752 | 0 | 1 |
mRNA-2752 + Tremelimumab | Tremelimumab mRNA-2752 | 0 | 1 |